Overdose Prevention
We conduct epidemiologic and intervention research on how to improve the safety of opioid prescribing among Kaiser Permanente members and the larger community. We are committed to finding ways to develop, test, and deliver effective strategies to prevent overdoses from pharmaceutical opioids, heroin, fentanyl, and other drugs. Our patient-centered approaches focus on ways individuals can protect themselves and their families from overdose.
Overdose Prevention Researchers
Featured Projects
Investigator: Ingrid A. Binswanger, MD, MPH, MS
This project is an office-based Methadone versus Buprenorphine randomized pragmatic hybrid effectiveness/implementation trial to address retention in medication for opioid use disorder treatment.
Funder: National Drug Abuse Clinical Trials Network, National Institute on Drug Abuse, NIH
Study End Date: 02/28/2028
This project is an office-based Methadone versus Buprenorphine randomized pragmatic hybrid effectiveness/implementation trial to address retention in medication for opioid use disorder treatment.
Funder: National Drug Abuse Clinical Trials Network, National Institute on Drug Abuse, NIH
Study End Date: 02/28/2028
Investigators: Ingrid A. Binswanger, MD, MPH, MS and Jason Glanz, PhD
This study examines the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.
Funder: National Institute on Drug Abuse
Study End Date: 04/30/2022
This study examines the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.
Funder: National Institute on Drug Abuse
Study End Date: 04/30/2022
Investigators: Ingrid A. Binswanger, MD, MPH, MS and Jason Glanz, PhD
The major goal of this project is to conduct a longitudinal cohort study to determine the effectiveness and safety of opioid tapering in three large health systems in two states.
Funder: National Institute on Drug Abuse
Study End Date: 12/31/2023
The major goal of this project is to conduct a longitudinal cohort study to determine the effectiveness and safety of opioid tapering in three large health systems in two states.
Funder: National Institute on Drug Abuse
Study End Date: 12/31/2023
Investigator: Ingrid A. Binswanger, MD, MPH, MS
The purpose of this study is to use a prescription opioid registry containing EHR data across nine diverse health systems to assess how different lengths of buprenorphine retention are related to mortality.
Funder: National Institute on Drug Abuse
Study End Date: 05/31/2021
The purpose of this study is to use a prescription opioid registry containing EHR data across nine diverse health systems to assess how different lengths of buprenorphine retention are related to mortality.
Funder: National Institute on Drug Abuse
Study End Date: 05/31/2021
Investigator: Ingrid A. Binswanger, MD, MPH, MS
The goal of this study is to evaluate the effects of opioid prescribing policies on heroin overdose within a large health system.
Funder: Centers for Disease Control and Prevention
Study End Date: 08/31/2020
The goal of this study is to evaluate the effects of opioid prescribing policies on heroin overdose within a large health system.
Funder: Centers for Disease Control and Prevention
Study End Date: 08/31/2020